Develops non-opioid pain management products for acute and chronic pain.
Jun 2026Revenue $31.6M/yrExpenses $391M/yr
No trendCash runway ≈ 1 months from Jun 2026
Figures by year
When will Scilex Holding be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $31.6M and expenses $391M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $30.3M | $376M | −$346M |
| Dec 2024 | $56.6M | $140M | −$83.4M |
| Dec 2023 | $46.7M | $152M | −$105M |
| Dec 2022 | $38.0M | $88.7M | −$50.6M |
| Dec 2021 | $31.3M | $67.2M | −$35.8M |
| Dec 2020 | $23.6M | $58.8M | −$35.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.